Search Results - "ESSAH, PAULINA A"

POSITION STATEMENT: Glucose Intolerance in Polycystic Ovary Syndrome—A Position Statement of the Androgen Excess Society by Salley, Kelsey E. S., Wickham, Edmond P., Cheang, Kai I., Essah, Paulina A., Karjane, Nicole W., Nestler, John E.

“…Objectives: Women with polycystic ovarian syndrome (PCOS) are at increased risk for developing glucose intolerance and type 2 diabetes mellitus (DM)…”
Get full text

Association between the Current Use of Low-Dose Oral Contraceptives and Cardiovascular Arterial Disease: A Meta-Analysis by Baillargeon, Jean-Patrice, McClish, Donna K., Essah, Paulina A., Nestler, John E.

“…Context: The long-term cardiovascular safety of widely used oral contraceptives (OCs) is still debated, and no meta-analysis assesses the modern use of OCs and…”
Get full text

Evidence for metabolic and reproductive phenotypes in mothers of women with polycystic ovary syndrome by Sam, S, Legro, R.S, Essah, P.A, Apridonidze, T, Dunaif, A

“…Dyslipidemia is a feature of polycystic ovary syndrome (PCOS), but its pathogenesis remains controversial. We performed this study of mothers of women with…”
Get full text

Effect of combined metformin and oral contraceptive therapy on metabolic factors and endothelial function in overweight and obese women with polycystic ovary syndrome by Essah, Paulina A., M.D., M.S, Arrowood, James A., M.D, Cheang, Kai I., Pharm.D., M.S, Adawadkar, Swati S., M.D, Stovall, Dale W., M.D, Nestler, John E., M.D

“…In this randomized, double-blind, placebo-controlled study, 19 overweight women with polycystic ovary syndrome were randomized to a 3-month course of either…”
Get full text

Divergent effects of a combined hormonal oral contraceptive on insulin sensitivity in lean versus obese women by Cheang, Kai I., Pharm.D., M.S, Essah, Paulina A., M.D., M.S, Sharma, Susmeeta, M.B.B.S, Wickham, Edmond P., M.D, Nestler, John E., M.D

“…Objective To evaluate the effects of a commonly used combined hormonal oral contraceptive (OC) on carbohydrate metabolism in obese as compared with lean women…”
Get full text

Prevalence and Characteristics of the Metabolic Syndrome in Women with Polycystic Ovary Syndrome by Apridonidze, Teimuraz, Essah, Paulina A., Iuorno, Maria J., Nestler, John E.

“…The polycystic ovary syndrome (PCOS) is characterized by insulin resistance with compensatory hyperinsulinemia. Insulin resistance also plays a role in the…”
Get full text

Metabolic Effects of a Commonly Used Combined Hormonal Oral Contraceptive in Women With and Without Polycystic Ovary Syndrome by Adeniji, Adeola A, Essah, Paulina A, Nestler, John E, Cheang, Kai I

“…Data on combined hormonal oral contraceptives' (OCs) effects on metabolic changes in women with polycystic ovary syndrome (PCOS) have been conflicting and were…”
Get more information

Insulin-stimulated release of d - chiro -inositol–containing inositolphosphoglycan mediator correlates with insulin sensitivity in women with polycystic ovary syndrome by Cheang, Kai I, Baillargeon, Jean-Patrice, Essah, Paulina A, Ostlund, Richard E, Apridonize, Teimuraz, Islam, Leila, Nestler, John E

“…Abstract Some actions of insulin are mediated by inositolphosphoglycan (IPG) mediators. Deficient release of a putative d - chiro -inositol–containing (DCI)…”
Get full text

Effect of Macronutrient Composition on Postprandial Peptide YY Levels by Essah, Paulina A., Levy, James R., Sistrun, Sakita N., Kelly, Susan M., Nestler, John E.

“…Background: Peptide YY (PYY) is released from the distal small intestine and colon after meals and reduces appetite by increasing satiety. The amount of PYY…”
Get full text

Metabolic syndrome in women with polycystic ovary syndrome by Essah, Paulina A, Nestler, John E

“…The prevalence of the metabolic syndrome in polycystic ovary syndrome (PCOS) is high across all age groups. Dyslipidemia, particularly a decreased high-density…”
Get more information

Effect of Renin–Angiotensin System Inhibition on Cardiovascular Events in Older Hypertensive Patients with Metabolic Syndrome by Zreikat, Hala H, Harpe, Spencer E, Slattum, Patricia W, Mays, D’arcy P, Essah, Paulina A, Cheang, Kai I

“…Abstract Objective Metabolic syndrome (MetS) is associated with cardiovascular disease (CVD). Insulin resistance has been hypothesized as the underlying…”
Get full text

The Metabolic Syndrome in Polycystic Ovary Syndrome by ESSAH, PAULINA A, WICKHAM, EDMOND P, NESTLER, JOHN E

“…Approximately one-third to one-half of all women and adolescent girls with polycystic ovary syndrome (PCOS) has the metabolic syndrome, associated with…”
Get full text

Effects of short-term and long-term metformin treatment on menstrual cyclicity in women with polycystic ovary syndrome by Essah, Paulina A, Apridonidze, Teimuraz, Iuorno, Maria J, Nestler, John E

“…The purpose of this retrospective study was to compare the frequency of menstrual cyclicity between two groups of patients with polycystic ovary syndrome:…”
Get more information

Reduced Serum Glycodelin and Insulin-Like Growth Factor-Binding Protein-1 in Women with Polycystic Ovary Syndrome during First Trimester of Pregnancy by Jakubowicz, Daniela J., Essah, Paulina A., Seppälä, Markku, Jakubowicz, Salomon, Baillargeon, Jean-Patrice, Koistinen, Riitta, Nestler, John E.

“…The polycystic ovary syndrome (PCOS) is associated with an increased rate of early pregnancy loss (EPL). Hyperinsulinemia is an independent risk factor for EPL…”
Get full text

Dermatology of androgen-related disorders by Essah, Paulina A., Wickham, Edmond P., Nunley, Julia R., Nestler, John E.

“…Hyperandrogenism in women can be caused by various conditions, the most prevalent of which is polycystic ovary syndrome. Common dermatologic manifestations of…”
Get full text

Long-term effect of metformin on metabolic parameters in the polycystic ovary syndrome by Cheang, Kai I, Huszar, Jessica M, Best, Al M, Sharma, Susmeeta, Essah, Paulina A, Nestler, John E

“…Insulin resistance is a central feature of the PCOS and may increase cardiovascular risk. Owing to insulin resistance, the metabolic syndrome is more prevalent…”
Get more information

Prevalence and Characteristics of the Metabolic Syndrome in Women With Polycystic Ovary Syndrome by Apridonidze, Teimuraz, Essah, Paulina A, Iuorno, Maria J, Nestler, John E

“…Insulin resistance and consequent hyperinsulinemia are characteristic of polycystic ovary syndrome (PCOS). Insulin resistance also is a component of the…”
Get full text

Effect of combined metformin and oral contraceptive on metabolic factors and endothelial function in overweight and obese women with polycystic ovary syndrome by Essah, Paulina A, Arrowood, James A, Cheang, Kai I, Adawadkar, Swati S, Stovall, Dale W., Nestler, John E.

“…In this randomized, double-blind, placebo controlled study, 19 overweight women with PCOS were randomized to a 3-month course of either metformin plus combined…”
Get full text

Glucose intolerance in polycystic ovary syndrome--a position statement of the Androgen Excess Society by Salley, Kelsey E S, Wickham, Edmond P, Cheang, Kai I, Essah, Paulina A, Karjane, Nicole W, Nestler, John E

“…Women with polycystic ovarian syndrome (PCOS) are at increased risk for developing glucose intolerance and type 2 diabetes mellitus (DM). Recommendations for…”
Get full text

The pathophysiology of miscarriage in women with polycystic ovary syndrome. Review and proposed hypothesis of mechanisms involved by Essah, Paulina A, Cheang, Kai I, Nestler, John E

Get full text